๐
Zinbryta
daclizumab
Multiple Sclerosis
๐ซ Withdrawn
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Zinbryta is indicated in adult patients for the treatment of relapsing forms of multiple sclerosis (RMS).
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/zinbryta